Gen Paed Flashcards

1
Q

Facial capillary malformation / port wine stain

A

Associations: - Glaucoma - If eyelid involved - Sturge-Weber syndrome • V1/V2 CM plus ipsilateral leptomeningeal capillary malformation. 10% of facial CM • Epilepsy, hemiparesis, stroke-like events, intellectual disability, growth hormone abnormalities • MRI with gadolinium at age 1 year (may not detect changes before 1 year_ • Low dose aspirin may be recommended • Treatment of PWS - Pulsed dye laser

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Infantile Haemangiomas

A

Not present at birth • 80% of growth by 3 months of age • 80% of infantile haemangiomas stop growing by 5 months. Regression largely occurred by 5 years Associations PHACES LUMBAR Rx Propranolol SE hypotension, hypoglycaemia, GI, RESP High risk • Segmental >5cm face (PHACES, airway) • Segmental >5cm lumbar/perineal (LUMBAR) • Bulky lesion on face • Early white discoloration (marker ulceration) • Central face • Periorbital, perioral, perinasal (functional impair • Multiple haemangiomas (hepatic lesions, Heart F, TFT)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

PHACES syndrome

A

• Posterior fossa brain abnormalities • Segmental Haemangioma of the head/neck • Arterial abnormalities • Coarctation of aorta • Eye abnormalities • Sternum abnormalities • Present in 31% of infants with a segmental IH of the head/neck >22cm • Investigations: • MRA head and neck • Echocardiogram • Ophthalmology • If abnormal cerebrovasculature: • Risk of stroke • Start beta blocker more slowly and under observation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Haemangiomatosis

A

• >5 infantile haemangiomas • May be disseminated eg intrahepatic, intracranial • Risk of cardiac failure, hyperthyroidism • Investigations • USS liver • TFT • Beta blockers effective for intrahepatic IH

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Kasabach-Merritt phenomenon

A

Combination of: • Rapidly expanding vascular tumour • Consumptive coagulopathy • Thrombocytopaenia • Microangiopathic haemolytic anaemia • High mortality without treatment Reported with: • Kaposiform haemangioendotheliomas • Tufted angiomas • Not with infantile haemangiomas Investigations • FBC, Clotting, fibrin degradation products • MRI / MRA, angiography • Biopsy - consider • Management • Avoid blood products unless active bleeding • Sirolimus • Vincristine & Corticosteroids • Embolisation, surgery, alpha interferon, radiotherapy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

NF1 criteria

A
  1. Six or more café-au-lait spots or hyperpigmented macules >5mm in diameter in pre-pubertal children and 15mm post-pubertal 2. Axillary or inguinal freckles (>2 freckles) 3. Two or more typical neurofibromas or one plexiform neurofibroma 3. Optic nerve glioma 4. Two or more iris hamartomas (Lisch nodules), often identified only through slit-lamp examination by an ophthalmologist 5. Sphenoid dysplasia or typical long-bone abnormalities such as pseudarthrosis 6. First-degree relative (e.g. mother, father, sister, brother) with NF1
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Metabolic smells

A

Burnt sugar, curry, or maple syrup - Maple syrup urine disease Sweaty socks or cheese-like - Isovaleric acidaemia Fruity, ammoniacal - Methylmalonic acidaemia or propionic acidaemia Mouse urine, musty - Phenylketonuria CABBAGE LIKE - Tyrosinemia Malt or hops - Methionine malabsorption Cat urine. - 3-methylcrotonic acidaemia, 3-hydroxy-3-methylglutaric aciduria Fish-like - Trimethylaminuria and carnitine excess

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Hair stuff Alopecia

A

Hair stuff • Hypertrichosis = excessive hair growth • Hirsutism = androgen-dependent male pattern of hair growth • Hypotrichosis = deficient hair growth • Alopecia = hair loss Alopecia • Scarring vs non-scarring. Scarring is rare in children, and is most often due to prolonged/untreated inflammatory conditions (e.g pydoerma, tinea). • 4 categories o Congenital diffuse o Congenital localised o Acquired diffuse o Acquired localised (most common) – usually due to: traumatic alopecia, alopecia areata, or tinea capitis. Alopecia areata • Rapid scalp hair loss in circles, band (ophiasis pattern as pictured), total (totalis) or whole of body (universalis). Usually children/young adults. Also has nail pit changes. NORMAL SCALP macroscopically, with microscopic infiltration of inflammatory cells. • Strong autoimmune association – Hashimoto thyroiditis, Addison d, pernicious anaemia, ulcerative colitis, myasthenia gravis, collagen vascular disease, vitiligo, DM1. Also Down synd. Often have autoantibodies present. • Cause unknown – presumed autoimmune. • Usually resolve in 6-12 months. Prognosis worse if young, extensive hair loss, recurrent. Traumatic alopecia • Traction alopecia o Trauma to hair follicles from tight braids, ponytails, bands, curlers, rollers etc. o Broken hairs, inflammatory follicular papules in circular patches, may have regional lymphadenopathy. • Hair pulling o Usually an acute childhood reaction to stress. • Trichotillomania o Compulsive pulling, twisting and breaking hair. o Hair loss is patchy and incomplete, with broken hair of various lengths. Scalp is normal, or has haemorrhage, crusting, chronic folliculitis. o DSM-IV classification: visible hair loss due to pulling, mounting tension preceding, gratification following, no other cause. o May be associated with trochophagy (resulting in trichobezoars), or OCD (in which case treatment with fluoxetine may help along with behavioural intervention). Acquired diffuse hair loss • Telogen effluvium o Sudden loss of large amounts of hair diffusely, when comb hair. o Due to premature conversion of growing hairs (anagen) to resting hairs (telogen). o Preceded 1.5-3 months by a precipitating cause: childbirth, fevers, surgery, acute blood loss, severe weight loss, cease steroids, psych stress. o Resolves withing 6 months. • Toxic alopecia o Acute, severe, diffuse, inhibition of anagen hair growth. o Due to chemotherapy, radiation, etc. Congenital diffuse • Structural defects • Trichorrhexis nodosa o Autosomal dominant, dry, brittle, lustreless hair. May be associated with Menkes kinky hair syndrome. Can also be acquired. • Pili torti o Spangled, brittle, coarse hair of different lengths. o Due to structural defect in hair shaft. May be associated with Menkes kinky hair syndrome. • Menkes kinky hair syndrome (trichopoliodystrophy) o X-linked recessive (males only). Due to gene mutation encoding copper transporting gene => maldistribution of copper in body and deficiency. o Neonatal hypothermia, hypotonia, poor feeding, seizures, failure to thrive. Pigmented skin, thin cheeks, depressed nasal bridge. Progressive psychomotor retardation in early infancy. o Hair normal at birth, then replaced by short, fine, brittle, light-coloured hair with features of pili torit or trichorrhexis. • Monilethrix o Autosomal dominant hair shaft defect. May affect eyebrows, lashes, body, pubic, scalp – initially normal at birth. • Trichothiodystrophy o May be isolated or in association with syndromes of intellectual impairment, short stature, ichthyosis, nail dystrophy, dental caires, cataracts, decreased fertility, neuro, bone, immunodeficiency. o Characteristically receding chin, protruding ears, raspy voice, sociable personality. • Bamboo hair (trichorrhexis invaginata) o Short, sparse, fragile, not grow. Nethertons • Pili annulati o Light/dark hair band alternation. ?variation of normal blond hair. • Wooly hair disease o Tight, curly hair in non-Black person. • Uncombable hair syndrome (spun glass hair) o Disorderly, silvery blond, triangular hair shafts and follicles.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Gianotti Crosti Syndrome (papular acrodermatitis of childhood)

A

Common young children (6mo-12yrs, peak 1-6) Symmetric rash - red or skin coloured appears over 3-4 days, typically a profuse eruption of dull red spots develops first on the thighs and buttocks, then on the outer aspects of the arms, and finally on the face. The rash is often asymmetrical and not usually itchy The individual spots are 5–10 mm in diameter and are a deep red colour. Later they often look purple, especially on the legs, due to leakage of blood from the capillaries. They may develop fluid-filled blisters (vesicles). Occurs in reaction to viral illness (Hep B, EBV, CMV, entero), lasts 3-6 weeks

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Webers and Rinne

A

WEBERS - tuning fork (512Hz) centre of forehead. Normal - sound in middle If Louder in one ear - SNHL on quieter side - CHL on louder side Rinne to distinguish between 2 Place tuning fork in 2 places - on mastoid process (bone conduction) and adjacent to ear (air conduction) Normal = air > bone = Rinne +ve Abnormal = bone>air = Rinne -ve (CHL on that side)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Mechanism NAC in paracetamol OD

A

Paracetamol OD - large amounts of hepatotoxic metabolite NAPQI produced. NAPQI normally inactivated by glutathione, in paracetamol OD, glutathione reserves depleted. NAC is precursor of glutathione so therefore replenishes reserves inactivating hepatotoxic NAPQI

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Cytochrome 450 inducers/inhibitors

A

Cytochrome P450 enzymes are essential for the metabolism of many medications. Although this class has more than 50 enzymes, six of them metabolize 90 percent of drugs, with the two most significant enzymes being CYP3A4 and CYP2D6. Genetic variability (polymorphism) in these enzymes may influence a patient’s response to commonly prescribed drug classes. CYP2D6 metabolizes many beta blockers, antidepressants, and opioids (7% white people are poor metabolisers of this). Cytochrome P450 inducers Reduce the concentration of drugs metabolised by the cytocrome P450 system. Mnemonic: CRAPS out drugs Carbamazepine Rifampicin bArbituates Phenytoin St Johns wort Cytochrome P450 inhibitors Increase the concentration of drugs metabolised by the cytocrome P450 system. Mnemonic: Some Certain Silly Compounds Annoyingly Inhibit Enzymes, Grrrrrrr Sodium valporate Ciprofloxacin Sulphonamide Cimetidine/omeprazole Antifungals, (AZOLES) amiodarone Isoniazid Erythromycin/clarithromycin Grapefruit juice Examples of drugs which interact with enzyme inhibitors/inducers Warfarin COCP Theophylline Corticosteroids Tricyclics Pethidine Statins Calcineurin inhibitors (Ciclosporin / tacrolimus)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Newborn screening

A

The current conditions screened for by the Newborn metabolic screening test are: • Amino acid disorders (for example PKU and MSUD)* • Fatty acid oxidation disorders (for example MCAD)* • Congenital hypothyroidism (CH) (1 in 4000 infants) TSH level • Cystic fibrosis (CF) immunoreactive trypsin • Congenital adrenal hyperplasia (CAH) 17-OHP • Galactosaemia • Biotinidase deficiency • Severe combined immune deficiency (SCID). T cell receptor excision circles (TRECs)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

JIA

A

Occurs before 16 yrs age

Chronic synovitis +/- extra-articular features

Features of involved joints: early morning stiffness, swelling, warm, restricted movement, contracture and bony deformities

Subtypes:

  • Oligoarticular: ≤ 4 usually large lower limb joints in first 6/12 of disease
  • Polyarticular: > 4 joints involved by 6/12
  • Systemic onset - clinical diagnosis of exclusion (ddx infection, malignancy, vasculitis)
  • Enthesitis related arthropathy
  • Reactive arthritis

Systemic onset JIA: Arthritis and fever Plus 1 of:

  • Evanescent rash
  • Lymphadenopathy
  • Hepatosplenomegaly
  • Serositis
  • Polyarthritis
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

POTS diagnosis and management

A

Diagnostic Criteria in adolescents: • Increase in heart rate>40bpm within 10minutes of moving from supine to upright position • Heart rate >130bpm • Symptoms Management  Increase blood volume • Increase fluid and salt intake  Exercise • Minimise deconditioning • Start low (recumbent) and slow • Increasing levels of ‘normal’ exercise (upright, enjoyed previously)  Compression stockings  Medication • Fludrocortisone - Increase salt retention and blood volume • Beta blockers - Slow heart rate, reduce vasodilatation • Alpha agonist (Midodrine)- Vasoconstriction  Support • Minimise social isolation • Psychology input • School plan

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

ARFID

A

 Disturbance in eating or feeding, as evidenced by one or more of: • Substantial weight loss (or, in children, absence of expected weight gain) • Nutritional deficiency • Dependence on a feeding tube or dietary supplements • Significant psychosocial interference  Disturbance not due to unavailability of food, or to observation of cultural norms  Disturbance not due to anorexia nervosa or bulimia nervosa, and there is no evidence of disturbance in experience of body shape or weight  Disturbance not better explained by another medical condition or mental disorder, or when occurring concurrently with another condition, the disturbance exceeds what is normally caused by that condition May also display other abnormalities with eating, such as: • avoidanceoffoodsbasedonsensoryqualities,such as texture, smell, or taste • restrictionoffoodintakeduetofear/anxietyabout gagging, choking, or vomiting. Significant nutritional deficiencies may occur  More males (30%) than AN (14%) or BN (6%) Management  Refeeding Anxiety Management Exposure therapy / Increase range of foods Cognitive behavioural therapy

17
Q

Congenital Torticollis

A

1.5 males : 1 female Evident by 2-4 weeks of age  Well circumscribed ‘mass’ may be palpable in the inferior one-third of the affected SCM Important to check:  Eye movements and vision  Spine for any asymmetry  Neurological exam Associated with plagiocephaly Possible association with congenital hip dysplasia Mx Incidence of spontaneous resolution unknown If untreated may lead to facial asymmetry Early physiotherapy leads to faster resolution  Positioning / tummy time  Environmental adaptations to encourage head turn  Passive stretching Consider imaging if atypical features Surgery if persistent with poor range of movement and significant asymmetry after 6- 12 months RED FLAGS Sudden onset Onset after 6 months of age Abnormal eye movements or vision Abnormal neurological exam Prognosis With first line interventions:  Positional – 99% resolve, none required surgery  Muscular – 94% resolve, 3.2% surgery  SCM mass – 88% resolve, 7.6% surgery

18
Q

Development age stacking blocks

A

1 year - 2 cubes 18months- 3-4 cubes 2years - 6 cubes 3years - 9 cubes or bridge

19
Q

Draw person with 3 parts 6 parts

A

Age 3: 3 parts 4: 4-6 parts 5: 5-10 parts 6: 12-14 parts

20
Q

Age can draw shapes

A

Scribble - 12 months Line – 2 years Circle – 3 years Cross – 4 years Square – 5 years Triangle – 6 years

21
Q

% speech that is intelligible 2 ; 3 ; 4 years

A

2: 50% 3: 75% 4: 100%

22
Q

2 word sentences Use 50+words Feeds doll 50% speech intelligible 6 cubes Wash, dry hands, brush teeth Helping get dressed Kick ball, throw overhead Age

A

2 years

23
Q

Copy circles 3 word sentences Ride tricycle Thumb wiggle 4 colours broad jump 75% speech intelligible

A

3 years

24
Q

Therapeutic index

A

TD(dose causes toxic effect in 50%) / ED (dose therapeutic in 50%)

25
Q

Number of T1/2 to reach steady state

A

5

26
Q

Bioavailability of drug

A

AUC x po dose / AUC x IV dose Relative bioavailability measures the bioavailability of a certain drug when compared with another formulation of the same drug, usually an established standard, or through administration via a different route. When the standard consists of intravenously administered drug, this is known as absolute bioavailability. Relative bioavailability = (AUCA x DoseB) / (AUCB x DoseA)

27
Q

Vd

A

Dose/ plasma concentration Vd determines loading dose = Vd x weight x target concentration Low Vd - highly protein bounds, mostly intravascular High Vd - high tissue binding, mostly extravascular

28
Q

Adjustment of drug dose when altered by disease

A

new dose = % cleared by non renal + % dose cleared by renal %renal cleared - new dose = usual dose x new GFR/old GFR

29
Q

Visual field defects

A
30
Q

Types of study design

A
31
Q

p450 inducers / inhibitors

SICKFACES.com

CRAP GPS

A
32
Q

Causes of cataracts

Congenital

Acquired

A

Causes of a congenital cataract

  • Idiopathic
  • Intrauterine infection (TORCH)
  • Genetic without systemic problems (autosomal dominant, recessive and X-linked inheritance)

• Genetic with systemic problems:

  • Autosomal dominant – hereditary spherocytosis, myotonic dystrophy, incontinentia pigmenti (rare), Marshall syndrome
  • Autosomal recessive (rare) – congenital ichthyosis, Conradi disease, Smith–Lemli–Opitz syndrome, Siemens’ syndrome
  • X-linked inheritance (rare) – Lowe syndrome
  • Chromosomal abnormalities (trisomy 21, 18 and 13) and Turner syndrome
  • Metabolic disorders – galactosaemia, galactokinase deficiency and hypocalcaemia
  • Maternal factors, e.g. diabetes mellitus, and drugs in pregnancy, e.g. corticosteroids and chlorpromazine

Causes of acquired cataract

  • Drugs such as corticosteroids
  • Trauma
  • Metabolic disorders (e.g. diabetes mellitus, hypothyroidism, hypocalcaemia and pseudohypoparathyroidism)
  • Radiotherapy
  • Infections – varicella, herpes simplex and Toxocara canis
  • Atopic dermatitis
  • Genetic conditions with later presentations such as Down syndrome, myotonic dystrophy, nail–patella syndrome, Alport syndrome, Wilson disease, Laurence–Moon–Biedl syndrome, Cockayne

syndrome
• Cataract of prematurity
• The most common chromosomal abnormality associated with cataract is trisomy 21 usually later in life

33
Q

Childhood glaucoma

A

CHILDHOOD GLAUCOMA

Definition: damage of the optic nerve with visual field loss caused by, or related to, elevated pressure within the eye. Normal intraocular pressure in infants and young children is <20 mmHg.

Congenital glaucoma begins within the first 3 years of life, juvenile glaucoma between the age of 3 and 30 years.

Classification broadly into:

  • primary congenital glaucoma caused by an intrinsic disorder of the aqueous outflow mechanism
  • secondary glaucoma caused by other ocular diseases or systemic abnormalities

When the intraocular pressure is raised in young children, the cornea usually becomes diffusely oedematous and enlarged. When the corneal diameter increases, splits occur in Descemet membrane and damage occurs to the corneal endothelial cells. If intraocular pressure is raised in a child under 2 years of age the eye may enlarge. This is referred to as ‘buphthalmos’ (ox-eye).

Clinical manifestations

Symptoms include the classic triad of epiphora (tearing), photophobia and blepharospasm (eyelid squeezing) secondary to corneal irritation. However, only 30% of affected infants demonstrate the classic symptom complex. Epiphora in glaucoma is differentiated from nasolacrimal duct obstruction by the presence of rhinorrhoea. When the nasolacrimal duct is obstructed, rhinorrhoea is absent. Other signs include corneal oedema, corneal and ocular enlargement, conjunctival injection and visual impairment.

Primary congenital glaucoma

This is caused by an intrinsic disorder of the aqueous outflow drainage – more than 50% of glaucoma is primary; 1 in 10,000 births. Usually bilateral.

Associated ocular problems:

  • Aniridia
  • Sturge–Weber syndrome
  • Neurofibromatosis
  • Hypomelanosis of Ito
  • Marfan syndrome
  • Lowe syndrome
  • Congenital rubella syndrome

Secondary glaucoma

Associated conditions are inflammatory eye disease (in association with juvenile idiopathic arthritis [JIA]), ectopia lentis and complications of surgery for congenital cataract.

Management of glaucoma

If untreated, glaucoma will inevitably lead to visual loss. Amblyopia is a major complication in unilateral glaucoma. The treatment remains surgical in most of the cases but sometimes medical treatment with drugs and laser therapy may help.

  • Surgical: to establish more normal anterior chamber angle (goniotomy and trabeculectomy) or to reduce aqueous fluid production (cyclocryotherapy and photocyclocoagulation).
  • Medical: β blockers (e.g. timolol) which act by lowering intraocular pressure.
34
Q

Retinitis Pigmentosa

A

Retinitis pigmentosa (RP): a pigmentary retinopathy characterized by night blindness (earliest symptom), progressive loss of peripheral visual field and loss of central vision (final symptom). Symptoms may be present in childhood, but usually do not become apparent until the second or third decade of life.

Early retinal changes shows pigment deposition as seen in the midperipheral retina, progressing to more diffuse pigment.

Systemic associations include:

  • Abetalipoproteinaemia
  • Refsumdisease
  • Usher syndrome
  • Laurence–Moon–Biedl syndrome

• Kearns–Sayre syndrome

35
Q

Aciclovir mechanism of action

A

Inhibits DNA polymerase which disruprs viral replication

36
Q

Pentalogy of Cantrell

A

Pentalogy of Cantrell consists of

  1. ectopia cordis,
  2. midline supraumbilical abdominal defect
  3. deficiency of the anterior diaphragm
  4. defect of the lower sternum, and
  5. an intracardiac defect (either a ventricular septal defect, tetralogy of Fallot, or diverticulum of the left ventricle).
37
Q

Measles

Incubation period

isolation precautions / infectivity

Management

A

Usually 8-12 days between exposure and onset of symtpoms (14 days to onset of rash)

Infective from 5 days before rash to 2 days after

IgM +ve from a few days after rash onset, remains positive for 30-60days

If non immune and exposed

  • infant <6mo - give MMR within 72hrs
  • immunocompromised or >72hrs and <6days consider NHIG

Isolation

in hospirtal - D5-21 post exposure need airborne prec

Community: from 7 days after 1st exposure to 14 days after last (extends to 18 days if had NHIG)

38
Q

Sites of bruises concerning for abuse

A

TEN4FACES

  • Torso
  • Ears
  • Neck
  • Frenulum
  • Angle of jaw
  • Cheek
  • Eyelid
  • Subconjunctiva
  • Age <4months
  • Patterned bruises